Skip to main content
LGVN
NASDAQ Life Sciences

Longeveron Repays Executive Pay Cuts, Grants Significant RSU Awards Amidst Financial Distress

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$1.13
Mkt Cap
$26.991M
52W Low
$0.475
52W High
$1.83
Market data snapshot near publication time

Summary

Longeveron Inc. repaid executive compensation reductions and approved substantial RSU grants, totaling approximately 1.25 million shares, following a recent financing transaction.


Key Events

  • Executive Compensation Restored

    Longeveron repaid executive officers and Board members for temporary compensation reductions implemented in February 2026, following a recent financing transaction.

  • Significant RSU Grants Approved

    The Compensation Committee approved grants of 500,000 Restricted Stock Units (RSUs) for the CEO and 250,000 RSUs for other executives, vesting quarterly over three years starting July 1, 2026.

  • Potential Dilution from RSUs

    These RSU grants represent a potential dilution of approximately 1.25 million shares, or over 5% of the company's estimated outstanding shares.

  • Context of Financial Distress

    This compensation action follows the company's disclosure of substantial doubt about its ability to continue as a going concern and a recent highly dilutive financing transaction.


Analysis

This filing reveals Longeveron has reversed temporary executive and board compensation cuts, indicating the company has secured some capital, likely from the deeply discounted private placement mentioned in its recent 10-K and the S-1 filed today. While the repayment addresses prior compensation reductions, the approval of significant Restricted Stock Unit (RSU) grants, potentially adding over 5% to the outstanding share count, introduces further dilution. This comes at a critical time for the company, which previously disclosed substantial doubt about its ability to continue as a going concern. Investors should note the ongoing dilution as the company attempts to stabilize its financial position.

At the time of this filing, LGVN was trading at $1.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $27M. The 52-week trading range was $0.48 to $1.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LGVN - Latest Insights

LGVN
Jun 09, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7855
Real-time Price: $0.7826 info
Change: -$0.0029 (-0.37%) info
Market Cap: $24.756M info
LGVN
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.730
Real-time Price: $0.7826 info
Change: +$0.0526 (+7%) info
Market Cap: $24.756M info
LGVN
May 20, 2026, 4:11 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.7826 info
Change: +$0.0026 (+0.33%) info
Market Cap: $24.756M info
LGVN
May 20, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.7826 info
Change: +$0.0026 (+0.33%) info
Market Cap: $24.756M info
LGVN
May 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7697
Real-time Price: $0.7826 info
Change: +$0.0129 (+2%) info
Market Cap: $24.756M info
LGVN
May 08, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.834
Real-time Price: $0.7826 info
Change: -$0.0514 (-6%) info
Market Cap: $24.756M info
LGVN
May 08, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7651
Real-time Price: $0.7826 info
Change: +$0.0175 (+2%) info
Market Cap: $24.756M info
LGVN
May 05, 2026, 5:42 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8561
Real-time Price: $0.7826 info
Change: -$0.0735 (-9%) info
Market Cap: $24.756M info
LGVN
Apr 17, 2026, 4:23 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.13
Real-time Price: $0.7826 info
Change: -$0.3474 (-31%) info
Market Cap: $24.756M info
LGVN
Apr 10, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $0.7826 info
Change: -$0.3378 (-30%) info
Market Cap: $24.756M info